The discovery of a new and unusual member of the chemokine family illustrates the importance of chemoattractant diversity in the regulation of leukocyte movement through the body. The chemokines are now divisible into four clearly defined subgroups on the basis of structural and functional properties.
Five years ago, very few people knew much about chemokines. Interest in these small proteins centred on their role as chemoattractants that recruit phagocytic cells from the blood to local sites of infection. But with the recent discovery that human immunodeficiency virus-1 (HIV-1) uses chemokine receptors for entry into cells [1] , the status of chemokines has been raised considerably. Indeed, the use of chemokine receptors explains the entry of HIV-1 strains into different types of leukocytes, and also the resistance to infection, despite repeated exposure, of individuals who have a mutant form of the chemokine receptor CCR5. These observations have spurred intense efforts to develop antagonists of chemokine receptors to inhibit HIV-1 transmission [2] . Over the last few years, however, there has been another, more subtle development in chemokine research. Steadily, the number of known chemokines is expanding to form a huge subset of the cytokines that far outnumbers other cytokine families, such as the tumor necrosis factor (TNF) family. The large number and variety of chemokines is indicative of the importance of these molecules, and suggests that diversity in the chemokine system, rather than diversity in the adhesion system, is important for regulating leukocyte movement through tissues.
Until recently, only two groups of chemokines had been characterized. These were termed the CXC and CC families according to the presence or absence of an amino acid (X) between a pair of cysteine residues near the amino terminus of the protein (Fig. 1 ). Interleukin-8 (IL-8), which attracts neutrophils, was regarded as the typical CXC chemokine [3] , whereas MCP-1, which attracts monocytes and T cells, was regarded as the typical CC chemokine [4] . Now that fast, automated sequencing of human and mouse genes has become commonplace, numerous other chemokines have been discovered and the story has become more complicated. There are now subsets within the CXC subgroup, including the 'ELR' subset, members of which contain a glutamate-leucine-arginine amino-acid motif near their amino termini and which attract neutrophils, IP-10 and Mig, which attract activated T cells, and stromal-cell-derived factor-1 (SDF-1), which attracts lymphocytes (Fig. 1) . A chemokine discovered last year, termed lymphotactin, has only a single cysteine near the amino terminus; this C chemokine appears to attract lymphocytes [5] .
Figure 1
The four families of chemokines are distinguished by the pattern of cysteine residues near the amino terminus. The CXC family has an amino acid between two cysteines; the CC family has none; the C family has only one cysteine; and the CX 3 C family, which has only one known member, has three amino acids between two cysteines. Certain sub-families exist within the CXC and CC families, which can be distinguished by sequence similarity and functional properties. The CX 3 C chemokine comprises a chemokine module, related in structure to the other families, as well as a stalk, a transmembrane region (TM), and a short cytoplasmic region (Cyt). The proportions of these components are not drawn to scale, as the stalk comprises approximately 75% of the CX 3 C chemokine. • Lymphotactin, SCM-1
• CX 3 C chemokine (fractalkine)
Sub-families Family
The most significant of the newly discovered chemokines has fundamentally different properties. This chemokine, termed CX 3 C chemokine, 'fractalkine' [6] or 'neurotactin' [7] , has three intervening amino acids between the aminoterminal cysteines (Fig. 1) . Just one more chemokine to add to the list may not seem all that important, but this new chemokine deviates significantly from the CXC, CC or C members. The sequence of this chemokine, unlike that of others which terminate at around 70-80 amino acids, continues for a further 241 residues. There is an 18-amino-acid hydrophobic sequence near the carboxyl terminus which is suggestive of a membrane-anchoring motif; this suggestion was confirmed by the transfection of cells with CX 3 C chemokine cDNA and detection of CX 3 C protein on the cell surface [6, 7] . Thus, the likely structure of this protein is a chemokine-like domain, perched on top of a stalk which sticks out from the cell membrane (Fig. 1) .
What is the function of this CX 3 C chemokine? Synthesis of CX 3 C chemokine, like that of most other chemokines, is induced during inflammatory reactions. This comes as no surprise, as the function of chemokines is to attract leukocytes, particularly in inflammatory settings. However, the association of CX 3 C chemokine with the membrane suggests that it may have interesting functions related to its immobility that contrast with the properties of the soluble chemokines. A good possibility is that CX 3 C chemokine expressed on the endothelial membrane provides a signal for circulating leukocytes during leukocyte extravasation. The exit of leukocytes from the blood is a multistep process, requiring not only adhesion events but also a signaling event [8, 9] . Chemokines are the prime candidates for such signaling [8, 9] , and are known to localize to endothelial surfaces through their capacity to bind proteoglycans [10] ; CX 3 C chemokine, however, already comes membrane-bound, and may be specialized for promoting leukocyte transit from the blood to tissues.
Interestingly, high levels of CX 3 C chemokine are made by endothelial cells, but not by leukocytes, suggesting that it is of particular importance for leukocyte recruitment from the blood [6, 7] , rather than for the attraction of leukocytes to other leukocytes. Bazan et al. [6] showed that monolayers of cells expressing CX 3 C chemokine could trigger the adhesion of T cells and monocytes under static conditions. Other chemokines, such as IL-8, mediate adhesiontriggering of cells under flow [11] , but the chemokines that trigger the adhesion of T cells to endothelium under flow have not been resolved [12] . CX 3 C chemokine may provide this function.
CX 3 C chemokine -in its guise as neurotactin -also appears to play an important role in the response to brain inflammation [7] . Indeed, the brain contains numerous cells that express chemokines or chemokine receptors, but the role of these molecules is poorly understood. The synthesis of CX 3 C chemokine in the brain is markedly upregulated during inflammation in both endothelial cells and microglia. The significance of the expression in microglia is uncertain; it is possible that membrane-bound CX 3 C chemokine may stimulate neighboring cells directly. In this context, membrane-bound CX 3 C chemokine may function in a similar way to other membrane-bound cytokines, such as TNF or steel factor. CX 3 C chemokine may also act as a diffusible chemokine. Chemoattractants work by generating a gradient from their source, so allowing appropriate receptor-bearing cells to discern an increase in chemokine concentration, and to move in the direction of the gradient. CX 3 C chemokine appears to be cleavable, and the chemokine module of the assembly attracts T cells and monocytes [6, 7] , and possibly neutrophils [7] . Whether cleavable CX 3 C chemokine has an important role in vivo is not yet known. Presumably CX 3 C chemokine(s) signals through a seven-transmembrane-spanning, G-protein-coupled receptor(s), as virtually all chemoattractants use this type of receptor, even in Dictyostelium [13] . A number of new receptors have recently been reported, and their ligands have been identified (Table 1) . As with the growing number of chemokines that have been identified, the growing number of chemokine receptors attests to the importance of this system for regulating leukocyte traffic. Numerous CC and CXC chemokine receptors have been characterized, although the receptors for C and CX 3 C chemokines are as yet unknown. Identifying these latter receptors will be important for understanding various aspects on the biology of the C and CX 3 C chemokines. The discovery of this fourth type of chemokine raises questions about the evolutionary history of CX 3 C and the other chemokines. The CXC, CC, C and CX 3 C chemokine genes map to human chromosomes 4, 17, 1 and 16, respectively. There are some exceptions, for instance SDF-1 maps to chromosome 10, and this chemokine may in fact represent a separate chemokine family [14] . The nature of the primordial chemokine, and its resemblance to the four known sub-groups of chemokine, will have to await studies with lower species. Irrespective of these issues, it is clear that the chemokines are a diverse and expanding family of molecules, and have a critical influence on inflammatory processes. Indeed, the control over leukocyte migration appears to depend more on the chemokines and their receptors, rather than on the interactions of the various adhesion molecules.
